People · Operator
Named in public records as an officer, director or promoter · active 2011–2012 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Diffinity Genomics Inc | — | Biotechnology | Pre-Seed | $1.4M | $37.4M | 2011 |
Michael Dean Riedlinger at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Dean Riedlinger on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Allen Evans | 1 | 1 |
| John Allen Foskett | 1 | 1 |
| Jeffrey L. Helfer | 1 | 1 |
| Lewis Josiah Rothberg | 1 | 1 |
| John Ferguson Foskett | 1 | 1 |
| Robin Joan Hodownes | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.